• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板减少性肝硬化患者行食管静脉曲张结扎术后低纤维蛋白原水平与出血相关。

Low Fibrinogen Levels Are Associated with Bleeding After Varices Ligation in Thrombocytopenic Cirrhotic Patients.

机构信息

Gastroenterology Unit, Department of Internal Medicine, University of Genoa, Ospedale Policlinico San Martino - IRCCS per l'Oncologia, Genoa, Italy.

出版信息

Ann Hepatol. 2018 Jun 5;17(5):830-835. doi: 10.5604/01.3001.0012.0775.

DOI:10.5604/01.3001.0012.0775
PMID:30145561
Abstract

INTRODUCTION AND AIM

EVBL is a procedure frequently performed in cirrhotic patients for primary prophylaxis of bleeding. Patients with cirrhosis display various degrees of alteration of common coagulation parameters, and it is not known whether these alterations may predict post-EVBL bleeding. To evaluate factors predictive of post-endoscopic variceal band ligation (EVBL) bleeding in cirrhotic patients with thrombocytopenia.

METHODS

We included 109 patients with cirrhosis undergoing EVBL for primary prophylaxis of variceal bleeding. Common coagulation parameters (INR, fibrinogen levels) and complete haemogram were obtained in all patients and evaluated subdividing patients in bleeders and non bleeders following EVBL.

RESULTS

The incidence of post-EVBL bleeding was 5.5% (6 patients). INR and platelet counts, considered as continuous or dichotomous variables according to common cut-offs (i.e., INR>1.5, platelet count <50x109/L) were not predictors of post-EVBL bleeding. Patients who bled had significantly lower fibrinogen levels [146 mg/dL (98 - 262) versus 230 mg/dL (104 - 638), P=0.009], and no other biochemical or clinical predictors of bleeding were identified. A fibrinogen cut-off of 179 mg/dL had 98.6% negative predictive value for bleeding.

CONCLUSION

low fibrinogen levels are associated with an increased risk of bleeding following prophylactic EVBL in cirrhotic patients, and might be used to stratify patients' risk. However, due to their preliminary nature, these findings need to be confirmed in larger populations.

摘要

简介和目的

EVBL 是肝硬化患者中经常进行的一种程序,用于原发性出血预防。肝硬化患者表现出各种程度的常见凝血参数改变,目前尚不清楚这些改变是否可预测 EVBL 后的出血。本研究旨在评估血小板减少症的肝硬化患者行 EVBL 后发生出血的预测因素。

方法

我们纳入了 109 例行 EVBL 以预防静脉曲张出血的肝硬化患者。所有患者均获得了常见凝血参数(INR、纤维蛋白原水平)和全血细胞计数,并根据 EVBL 后是否发生出血将患者分为出血组和非出血组进行评估。

结果

EVBL 后出血的发生率为 5.5%(6 例)。INR 和血小板计数,根据常见的截断值(即 INR>1.5、血小板计数 <50x109/L)被视为连续或离散变量,均不是 EVBL 后出血的预测因素。出血患者的纤维蛋白原水平明显较低[146mg/dL(98-262)比 230mg/dL(104-638),P=0.009],且未发现其他出血的生化或临床预测因素。纤维蛋白原截断值为 179mg/dL 时对出血的阴性预测值为 98.6%。

结论

在肝硬化患者中,预防性 EVBL 后纤维蛋白原水平较低与出血风险增加相关,可能用于分层患者的风险。然而,由于这些发现是初步的,因此需要在更大的人群中进行验证。

相似文献

1
Low Fibrinogen Levels Are Associated with Bleeding After Varices Ligation in Thrombocytopenic Cirrhotic Patients.血小板减少性肝硬化患者行食管静脉曲张结扎术后低纤维蛋白原水平与出血相关。
Ann Hepatol. 2018 Jun 5;17(5):830-835. doi: 10.5604/01.3001.0012.0775.
2
Risk factors for band-induced ulcer bleeding after prophylactic and therapeutic endoscopic variceal band ligation.预防性和治疗性内镜下静脉曲张套扎术后套扎所致溃疡出血的危险因素
Eur J Gastroenterol Hepatol. 2015 Aug;27(8):928-32. doi: 10.1097/MEG.0000000000000387.
3
A prospective study of conventional and expanded coagulation indices in predicting ulcer bleeding after variceal band ligation.一项关于传统凝血指标和扩展凝血指标预测静脉曲张套扎术后溃疡出血的前瞻性研究。
Clin Gastroenterol Hepatol. 2009 Sep;7(9):988-93. doi: 10.1016/j.cgh.2009.04.019. Epub 2009 May 4.
4
Preservation of platelet function in patients with cirrhosis and thrombocytopenia undergoing esophageal variceal ligation.肝硬化和血小板减少症患者在接受食管静脉曲张结扎术时血小板功能的保留
Hepatobiliary Pancreat Dis Int. 2020 Dec;19(6):555-560. doi: 10.1016/j.hbpd.2019.12.009. Epub 2020 Jan 11.
5
The international normalized ratio does not reflect bleeding risk in esophageal variceal hemorrhage.国际标准化比值不能反映食管静脉曲张出血的出血风险。
Saudi J Gastroenterol. 2015 Jul-Aug;21(4):254-8. doi: 10.4103/1319-3767.161646.
6
Endoscopic variceal band ligation compared with propranolol for prophylaxis of first variceal bleeding.内镜下食管静脉曲张套扎术与普萘洛尔预防首次静脉曲张出血的比较。
Ann Hepatol. 2011 Apr-Jun;10(2):142-9.
7
Predicting portal hypertension and variceal bleeding using non-invasive measurements of metabolic variables.利用代谢变量的无创测量预测门静脉高压和静脉曲张出血。
Ann Hepatol. 2013 Jul-Aug;12(4):588-98.
8
[Transient elastography as a predictor of oesophageal varices in patients with liver cirrhosis].[瞬时弹性成像作为肝硬化患者食管静脉曲张的预测指标]
Orv Hetil. 2014 Feb 16;155(7):270-6. doi: 10.1556/OH.2014.29824.
9
Novel insights into the assessment of risk of upper gastrointestinal bleeding in decompensated cirrhotic children.对失代偿期肝硬化儿童上消化道出血风险评估的新见解。
Pediatr Transplant. 2019 Jun;23(4):e13390. doi: 10.1111/petr.13390. Epub 2019 Mar 19.
10
Non-invasive predictors of the presence of large oesophageal varices in patients with cirrhosis.肝硬化患者食管大静脉曲张存在情况的无创预测指标
Dig Liver Dis. 2003 Jul;35(7):473-8. doi: 10.1016/s1590-8658(03)00219-6.

引用本文的文献

1
Establishment and validation of a nomogram for predicting esophagogastric variceal bleeding in patients with liver cirrhosis.肝硬化患者食管胃静脉曲张出血预测列线图的建立与验证
World J Gastroenterol. 2025 Mar 7;31(9):102714. doi: 10.3748/wjg.v31.i9.102714.
2
Relationship between platelet-to-lymphocyte ratio and early rebleeding after endoscopic variceal ligation: a bicenter retrospective study.血小板与淋巴细胞比值与内镜下食管静脉曲张套扎术后早期再出血的关系:一项双中心回顾性研究。
Ann Med. 2024 Dec;56(1):2400315. doi: 10.1080/07853890.2024.2400315. Epub 2024 Sep 6.
3
Assessing the Predictive Factors for Bleeding in Esophageal Variceal Disease: A Systematic Review.
评估食管静脉曲张疾病出血的预测因素:一项系统评价。
Cureus. 2023 Nov 17;15(11):e48954. doi: 10.7759/cureus.48954. eCollection 2023 Nov.
4
Minimum platelet count threshold before invasive procedures in cirrhosis: Evolution of the guidelines.肝硬化患者侵入性操作前的最低血小板计数阈值:指南的演变
World J Gastrointest Surg. 2023 Feb 27;15(2):127-141. doi: 10.4240/wjgs.v15.i2.127.
5
Rebalanced hemostasis in liver disease: a misunderstood coagulopathy.肝脏疾病中的再平衡止血:一种被误解的凝血障碍。
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):485-491. doi: 10.1182/hematology.2021000283.
6
Hemostasis testing in patients with liver dysfunction: Advantages and caveats.肝功能障碍患者的止血检测:优势和注意事项。
World J Gastroenterol. 2021 Nov 14;27(42):7285-7298. doi: 10.3748/wjg.v27.i42.7285.
7
Current Concepts in Coagulation Profile in Cirrhosis and Acute-on-Chronic Liver Failure.肝硬化和慢加急性肝衰竭凝血指标的当前概念
Clin Liver Dis (Hoboken). 2020 Nov 3;16(4):158-167. doi: 10.1002/cld.976. eCollection 2020 Oct.
8
Clinical Implications of Thrombocytopenia for the Cirrhotic Patient.血小板减少症对肝硬化患者的临床意义
Hepat Med. 2020 Apr 14;12:49-60. doi: 10.2147/HMER.S244596. eCollection 2020.
9
Anticoagulation in the cirrhotic patient.肝硬化患者的抗凝治疗。
JHEP Rep. 2019 Jul 16;1(3):227-239. doi: 10.1016/j.jhepr.2019.02.006. eCollection 2019 Sep.
10
Transfusion strategies in patients with cirrhosis.肝硬化患者的输血策略。
Eur J Haematol. 2020 Jan;104(1):15-25. doi: 10.1111/ejh.13342. Epub 2019 Nov 19.